Studies Provide Glimpse At Efficacy Ff Covid-19 Vaccines From Oxford-AstraZeneca StockWave

    • Investing

Covid-19 vaccine being developed by Oxford University and the drug giant
AstraZeneca generated an immune response in a study of roughly 1,000
patients, according to interim results

Covid-19 vaccine being developed by Oxford University and the drug giant
AstraZeneca generated an immune response in a study of roughly 1,000
patients, according to interim results

Top Podcasts In Investing